![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Changes in Cardiovascular Biomarkers in Subjects Switching from Ritonavir- Boosted Protease Inhibitors to Raltegravir: The SPIRAL Study
|
|
|
Reported by Jules Levin
CROI 2012 March 5-8 Seattle WA
E Martinez1, P Monteiro1, JM Llibre2, F Gutierrez3,
D Podzamczer4, A Antela5, J Berenguer6, I Perez1,
J Pich1, JM Gatell1, and the SPIRAL Study Group.
1 Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona;2 Germans Trias i Pujol University Hospital and Lluita contra la SIDA Foundation, Badalona; 3 Hospital General Universitario de Elche, Elche; 4 Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat; 5 Complexo Hospitalario Universitario de Santiago, Santiago de Compostela; and 6 Hospital General Universitario Gregorio Maranon, Madrid, all in Spain.
![CROI1.gif](../images/032012/032012-2/CROI1.gif)
![CROI2.gif](../images/032012/032012-2/CROI2.gif)
![CROI3.gif](../images/032012/032012-2/CROI3.gif)
![CROI4.gif](../images/032012/032012-2/CROI4.gif)
![CROI5.gif](../images/032012/032012-2/CROI5.gif)
![CROI6.gif](../images/032012/032012-2/CROI6.gif)
![CROI7.gif](../images/032012/032012-2/CROI7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|